These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1330622)

  • 1. Chronic d-amphetamine inhibits opioid receptor antagonist-induced supersensitivity.
    Duttaroy A; Billings B; Candido J; Yoburn BC
    Eur J Pharmacol; 1992 Oct; 221(2-3):211-5. PubMed ID: 1330622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity.
    Yoburn BC; Shah S; Chan K; Duttaroy A; Davis T
    Pharmacol Biochem Behav; 1995; 51(2-3):535-9. PubMed ID: 7667382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of opioid receptor upregulation and functional supersensitivity.
    Chang SC; Lutfy K; Sierra V; Yoburn BC
    Pharmacol Biochem Behav; 1991 Apr; 38(4):853-9. PubMed ID: 1651519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse.
    Yoburn BC; Nunes FA; Adler B; Pasternak GW; Inturrisi CE
    J Pharmacol Exp Ther; 1986 Oct; 239(1):132-5. PubMed ID: 3020228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat.
    Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
    Gen Pharmacol; 1993 Nov; 24(6):1351-7. PubMed ID: 8112506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of opioid receptor density in morphine tolerance.
    Lutfy K; Yoburn BC
    J Pharmacol Exp Ther; 1991 Feb; 256(2):575-80. PubMed ID: 1847202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic opioid antagonist treatment: assessment of receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Eur J Pharmacol; 1989 Nov; 170(3):193-200. PubMed ID: 2559854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity.
    Lee SC; Yoburn BC
    Pharmacol Biochem Behav; 2000 Jun; 66(2):347-51. PubMed ID: 10880689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone-sensitizing effects of centrally administered morphine and opioid peptides.
    Adams JU; Holtzman SG
    Eur J Pharmacol; 1991 Jan; 193(1):67-73. PubMed ID: 1675608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    Neuropharmacology; 1990 Sep; 29(9):805-10. PubMed ID: 1963479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation.
    Shah S; Duttaroy A; Chen BT; Carroll J; Yoburn BC
    Brain Res Bull; 1997; 42(6):479-84. PubMed ID: 9128924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS; Mosberg HI; Porreca F
    NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice.
    Duttaroy A; Shen J; Shah S; Chen B; Sehba F; Carroll J; Yoburn BC
    Life Sci; 1999; 65(2):113-23. PubMed ID: 10416817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.